SHC SHC
Company Profile ↓Company Overview
SHC (SHC) is a publicly traded company listed on with a market capitalization of $5.14B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Operating margin of 31.1% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $1.16B (+5.7% YoY); net profit $77.95M.
- Trailing 12 Months Year-on-year growth — revenue +5.7%, earnings +75.6%.
- 5-Year Trend Long-term compounding — revenue CAGR 8.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 8.38% |
| 1 Year: | 5.74% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 75.57% |
Stock Price Performance
| 1 Year: | +61.26% |
| 6 Months: | -0.44% |
| 3 Months: | +17.29% |
| 1 Month: | -0.22% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)57.46 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading at a high P/E of 66.6.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 188.20M | 213.09M | 200.03M | 212.15M | 251.92M | 226.16M | 236.75M | 266.64M | 248.70M | 220.59M | 255.28M | 263.18M | 248.18M | 276.59M | 285.47M | - | 254.52M | 294.34M | 311.31M | 303.44M | 280.05M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 119.09M | 127.72M | 133.75M | 137.52M | 132.98M |
| Gross Profit | 96.52M | 118.97M | 107.51M | 115.37M | 143.76M | 125.59M | 128.88M | 150.40M | 136.01M | 111.50M | 139.59M | 145.98M | 127.11M | 152.79M | 158.02M | - | 135.43M | 166.62M | 177.56M | 165.92M | 147.07M |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78.39M | 78.19M | 66.38M | 60.54M | 71.24M |
| Operating Income | 44.87M | 61.74M | 47.03M | 46.36M | 78.27M | 65.67M | 53.49M | 71.50M | 63.20M | 33.37M | 63.20M | 76.10M | 53.17M | 76.80M | 80.51M | - | 57.04M | 88.43M | 111.18M | 105.38M | 75.83M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 66.86M | 94.56M | 140.44M | 138.07M | 108.17M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 40.88M | 40.65M | 39.15M | 35.05M | 34.74M |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -14.82M | 18.90M | 72.94M | 70.50M | 42.61M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -1.56M | 10.94M | 24.54M | 35.65M | 16.02M |
| Net Income | -1.96M | 7.02M | 10.00K | 10.84M | 42.60M | 27.44M | 30.64M | 30.42M | 25.09M | - | 23.51M | -13.66M | - | 8.75M | 17.00M | - | -13.26M | 7.96M | 48.40M | 34.85M | 26.59M |
| Diluted EPS | -0.01 | 0.03 | 0.00 | 0.04 | 0.15 | 0.10 | 0.11 | 0.11 | 0.09 | 0.01 | 0.08 | -0.05 | 0.02 | 0.03 | 0.06 | - | -0.05 | 0.03 | 0.17 | 0.12 | 0.09 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 778.33M | 818.16M | - | 1.00B | 1.05B | 1.10B | 1.16B |
| Cost of Revenue | - | - | - | 446.68M | 472.13M | 498.15M | 518.08M |
| Gross Profit | 395.43M | 443.57M | - | 557.00M | 577.16M | 602.29M | 645.53M |
| Operating Expenses | - | - | - | 308.65M | 300.47M | 304.67M | 283.50M |
| Operating Income | 183.60M | 206.02M | - | 248.35M | 276.69M | 297.63M | 362.03M |
| EBITDA | - | - | - | -17.41M | 406.83M | 442.20M | 439.93M |
| Interest Expense | - | - | - | 80.14M | 142.88M | 164.69M | 155.72M |
| Pretax Income | - | - | - | -243.11M | 106.03M | 113.87M | 147.51M |
| Tax Provision | - | - | - | -9.54M | 54.65M | 69.48M | 69.56M |
| Net Income | -20.85M | -38.62M | - | -233.57M | 51.38M | 44.40M | 77.95M |
| Diluted EPS | -0.09 | -0.16 | - | -0.83 | 0.18 | 0.16 | 0.27 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 2.76B | - | 3.12B | 3.13B | 3.07B | 3.26B |
| Current Assets | - | - | - | - | 645.01M | 557.24M | 526.04M | 613.41M |
| Cash & Equivalents | - | - | 102.45M | - | 395.21M | 296.41M | 277.24M | 344.62M |
| Inventory | - | - | - | - | 37.15M | 48.32M | 49.16M | 54.38M |
| Receivables | - | - | - | - | 118.48M | 147.70M | 140.33M | 139.33M |
| Total Liabilities | - | - | 2.31B | - | 2.77B | 2.69B | 2.67B | 2.66B |
| Current Liabilities | - | - | 140.60M | - | 791.57M | 230.65M | 191.00M | 249.58M |
| Long Term Debt | - | - | 1.82B | - | 1.75B | 2.22B | 2.21B | 2.13B |
| Total Debt | - | - | - | - | 2.03B | 2.33B | 2.35B | 2.27B |
| Total Equity | 45.49M | -641.13M | 452.30M | - | 350.24M | 443.73M | 404.91M | 606.03M |
| Shares Outstanding | - | - | - | - | 286.04M | 286.04M | 286.04M | 286.04M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 149.04M | 120.58M | - | 277.96M | -147.73M | 224.16M | 287.19M |
| Investing Cash Flow | -57.26M | -158.69M | - | -181.90M | -214.91M | -179.00M | -135.14M |
| Financing Cash Flow | -126.03M | 73.43M | - | 197.76M | 265.96M | -50.56M | -100.53M |
| Capital Expenditure | -57.26M | -53.51M | - | -182.38M | -214.97M | -179.07M | -138.02M |
| Free Cash Flow | 91.78M | 67.08M | - | 95.58M | -362.71M | 45.09M | 149.18M |
| Net Change in Cash | - | - | - | 293.83M | -96.68M | -5.40M | 51.52M |
| Share Buybacks | 0 | 34.00M | 0 | 0 | - | - | - |
| Dividends Paid | 691.17M | 0 | 0 | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|
| Gross Margin % | 50.8% | 54.2% | - | 55.5% | 55.0% | 54.7% | 55.5% |
| Operating Margin % | 23.6% | 25.2% | - | 24.7% | 26.4% | 27.0% | 31.1% |
| Net Margin % | -2.7% | -4.7% | - | -23.3% | 4.9% | 4.0% | 6.7% |
| ROE % | 3.3% | -8.5% | - | -66.7% | 11.6% | 11.0% | 12.9% |
| ROCE % | - | 7.9% | - | 10.7% | 9.5% | 10.3% | 12.0% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SHC
What Makes Sotera Health (SHC) a Strong Position in Your Portfolio?
O’Keeffe Stevens Advisory, an investment advisory firm, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. During Q2 2026, the market experienced notable dispersion between perceived AI losers and…
2 Cash-Producing Stocks with Competitive Advantages and 1 We Brush Off
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.…
Sotera Health Announces Second-Quarter 2026 Earnings Release Date
CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announc…
3 Small-Cap Stocks That Fall Short
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to t…
3 Reasons SHC is Risky and 1 Stock to Buy Instead
Sotera Health Company currently trades at $17.92 per share and has shown little upside over the past six months, posting a small loss of 4.7%. The stock also fell short of the S&P 500’s 8% gain during that period.…
1 Profitable Stock Worth Your Attention and 2 We Brush Off
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.…
SHC — Frequently Asked Questions
What is the current share price of SHC?
As of 2026-08-05 17:25 PDT, SHC trades at $17.98 on NASDAQ/NYSE. Its 52-week range is $11.06 to $19.35.
What is the market capitalisation of SHC?
SHC has a market capitalisation of $5.14B on NASDAQ/NYSE.
What is the P/E ratio of SHC?
SHC trades at a trailing price-to-earnings (P/E) ratio of 66.59. Its price-to-book (P/B) ratio is 8.49.
What is the return on equity (ROE) of SHC?
SHC has a return on equity (ROE) of 12.86%. Its return on capital employed (ROCE) is 12.01%.
Is SHC a good stock to buy?
This page provides a data-driven analysis of SHC, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.